PFK-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of PFK-1 monoclonal antibodies for research focused on phosphofructokinase-1 in cellular metabolism. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphofructokinase-1 functions as a key regulatory enzyme in the glycolytic pathway, facilitating the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate. As a central component in energy production and metabolic regulation, phosphofructokinase-1 maintains essential cellular function and homeostasis. Research has shown that alterations in phosphofructokinase-1 activity are associated with various metabolic disorders and cancer, highlighting its significance as a target for therapeutic intervention. Understanding phosphofructokinase-1 regulation and function can provide valuable insights into metabolic disease mechanisms and potential treatment strategies. Investigating phosphofructokinase-1 activity patterns helps reveal crucial aspects of cellular energy metabolism and its role in disease progression. Exploring phosphofructokinase-1 expression levels across different tissues can uncover new therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of metabolic pathways and their impact on human health.